Is Neoadjuvant Therapy Sufficient in Resected Pancreatic Cancer Patients? A National Study

@article{Geus2017IsNT,
  title={Is Neoadjuvant Therapy Sufficient in Resected Pancreatic Cancer Patients? A National Study},
  author={Susanna W. L. de Geus and Gyulnara G. Kasumova and Mariam F. Eskander and Sing Chau Ng and Tara Sotsky Kent and Arthur James Moser and Alexander L Vahrmeijer and Mark P. Callery and Jennifer Tseng},
  journal={Journal of Gastrointestinal Surgery},
  year={2017},
  volume={22},
  pages={214-225}
}
Despite the increasing use of neoadjuvant treatment, the question of whether preoperatively treated, successfully resected patients should receive additional postoperative adjuvant treatment remains unanswered. We evaluate the impact of adjuvant therapy following neoadjuvant treatment and pancreatectomy in pancreatic cancer patients in a large national study. We used the National Cancer Data Base between 2006 and 2013 to identify resected, non-metastatic pancreatic adenocarcinoma patients who… CONTINUE READING